Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to -$510000.0.

  • OptimizeRx's Other Working Capital Changes fell 9844.36% to -$510000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $374000.0, marking a year-over-year decrease of 650.0%. This contributed to the annual value of $1.4 million for FY2024, which is 11883.04% up from last year.
  • Latest data reveals that OptimizeRx reported Other Working Capital Changes of -$510000.0 as of Q3 2025, which was down 9844.36% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, OptimizeRx's Other Working Capital Changes peaked at $2.3 million during Q2 2024, and registered a low of -$8.4 million during Q4 2023.
  • For the 5-year period, OptimizeRx's Other Working Capital Changes averaged around -$382889.8, with its median value being -$257000.0 (2024).
  • Per our database at Business Quant, OptimizeRx's Other Working Capital Changes crashed by 176507.18% in 2023 and then soared by 583947.37% in 2024.
  • Over the past 5 years, OptimizeRx's Other Working Capital Changes (Quarter) stood at $1.1 million in 2021, then plummeted by 140.63% to -$451618.0 in 2022, then plummeted by 1765.07% to -$8.4 million in 2023, then surged by 102.96% to $249000.0 in 2024, then crashed by 304.82% to -$510000.0 in 2025.
  • Its last three reported values are -$510000.0 in Q3 2025, $1.0 million for Q2 2025, and -$74000.0 during Q1 2025.